Fundraising FoxViveve Medical
Sunnyvale, US · Delaware corporation
Find your way into Viveve Medical
Sign up to see every warm intro you have to Viveve Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Viveve Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PS
Patricia SchellerChief Executive Officer
SD
Scott DurbinChief Financial Officer
MR
Mark R. TauscherExecutiveMark Tauscher has held executive roles in medical device companies including executive vice president of sales and marketing at Quinton, a cardiology products manufacturer, and division president at Marquette Medical Systems. He also spent time in sales and marketing management at Hewlett-Packard's Medical Products Group.
GW
Gregory W. MannExecutive
Board
BS
Brigitte SmithBoard director
CS
Carl SimpsonBoard director
MC
Mark ColellaBoard director
DJ
Daniel JanneyBoard director
BN
Brent NortonBoard director
BL
Benjamin L. HolmesBoard director
AS
Albert S. KyleBoard director
Reported raises · per SEC filings
Form D private placements$30.5M disclosed across 8 rounds · 2014–2022
▶$14.7KraisedOct 2022 · 1 investors · BiotechnologyRule 506(b)
▶$14.7KraisedOct 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sharon PresnellDirector
- Arlene MorrisDirector
- Steven BastaDirector
- Jim RobbinsExecutive Officer
- Debora JornDirector
- Scott DurbinExecutive Officer, Director
- Offering amount
- $14.7K
- Amount sold
- $14.7K
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$341.3KraisedJun 2020 · 1 investors · BiotechnologyRule 506(b)
▶$341.3KraisedJun 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven BastaDirector
- Jim RobbinsExecutive Officer
- Arlene MorrisDirector
- Debora JornDirector
- Sean ShapiroExecutive Officer
- Scott DurbinExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $341.3K
- Sales commissions
- $325K
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.2MraisedMay 2020 · 9 investors · BiotechnologyRule 506(b)
▶$3.2MraisedMay 2020 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jim RobbinsExecutive Officer
- Steven BastaDirector
- Arlene MorrisDirector
- Scott DurbinExecutive Officer, Director
- Sean ShapiroExecutive Officer
- Debora JornDirector
- Offering amount
- $3.2M
- Amount sold
- $3.2M
- Sales commissions
- $216.2K
- Placement agents
- Ladenburg Thalmann & Co. Inc.
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedDec 2015 · 12 investors · Other Health CareRule 506(b)
▶$6MraisedDec 2015 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel JanneyDirector
- James AtkinsonExecutive Officer
- Mark ColellaDirector
- Carl SimpsonDirector
- Patricia SchellerExecutive Officer, Director
- Jim RobbinsExecutive Officer
- Brigitte SmithDirector
- Scott DurbinExecutive Officer
- Offering amount
- $6M
- Amount sold
- $6M
- Sales commissions
- $480.1K
- Proceeds to insiders
- $594K
- Placement agents
- Maxim Group LLC, CRT Capital Group LLC
- First sale
- Nov 2015
- Incorporated
- Corporation, Yukon, Canada
- Federal exemptions
- 06b
▶$12MraisedMay 2015 · 20 investors · Other Health CareRule 506(b)
▶$12MraisedMay 2015 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brigitte SmithDirector
- Carl SimpsonDirector
- James AtkinsonExecutive Officer
- Patricia SchellerExecutive Officer, Director
- Mark ColellaDirector
- Scott DurbinExecutive Officer
- Daniel JanneyDirector
- Offering amount
- $12M
- Amount sold
- $12M
- Sales commissions
- $840K
- Placement agents
- CRT Capital Group, LLC
- First sale
- May 2015
- Incorporated
- Corporation, Yukon, Canada
- Federal exemptions
- 06b
▶$2.4MraisedOct 2014 · 23 investors · Other Health CareRule 506(b)
▶$2.4MraisedOct 2014 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel JanneyDirector
- Patricia Kimberly SchellerExecutive Officer, Director
- Carl SimpsonDirector
- Scott DurbinExecutive Officer
- Mark S ColellaDirector
- Brigitte SmithDirector
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- First sale
- Sep 2014
- Incorporated
- Corporation, Yukon, Canada
- Federal exemptions
- 06b
▶$500KraisedJun 2014 · 1 investors · Other TechnologyRule 506(b)
▶$500KraisedJun 2014 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- BENJAMIN L. HOLMESDirector
- BRENT NORTONDirector
- ALBERT S. KYLEDirector
- MARK R. TAUSCHERExecutive Officer, Director
- GREGORY W. MANNExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $500K
- First sale
- Apr 2014
- Incorporated
- Corporation, Yukon, Canada
- Federal exemptions
- 06b
▶$6MraisedJun 2014 · 28 investors · Other TechnologyRule 506(b)
▶$6MraisedJun 2014 · 28 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark R. TauscherExecutive Officer, Director
- Gregory W. MannExecutive Officer, Director
- Brent NortonDirector
- Benjamin L. HolmesDirector
- Albert S. KyleDirector
- Offering amount
- $6M
- Amount sold
- $6M
- Sales commissions
- $225K
- Placement agents
- Middlebury Securities, LLC
- First sale
- May 2014
- Incorporated
- Corporation, Yukon, Canada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Viveve Medical raised?
- Viveve Medical has disclosed $30.5M raised across 8 rounds.
- Where is Viveve Medical headquartered?
- Viveve Medical is headquartered in Sunnyvale, US.